- Home
- FRPH vs SIGA Comparison
FRPH vs SIGA Comparison
Compare FRPH & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPH
- SIGA
- Stock Information
- Founded
- FRPH 1986
- SIGA 1995
- Country
- FRPH United States
- SIGA United States
- Employees
- FRPH N/A
- SIGA N/A
- Industry
- FRPH Real Estate
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- FRPH Finance
- SIGA Health Care
- Exchange
- FRPH Nasdaq
- SIGA Nasdaq
- Market Cap
- FRPH 491.1M
- SIGA 515.1M
- IPO Year
- FRPH N/A
- SIGA 1997
- Fundamental
- Price
- FRPH $25.50
- SIGA $8.64
- Analyst Decision
- FRPH
- SIGA
- Analyst Count
- FRPH 0
- SIGA 0
- Target Price
- FRPH N/A
- SIGA N/A
- AVG Volume (30 Days)
- FRPH 40.2K
- SIGA 604.9K
- Earning Date
- FRPH 11-05-2025
- SIGA 11-06-2025
- Dividend Yield
- FRPH N/A
- SIGA 7.13%
- EPS Growth
- FRPH N/A
- SIGA N/A
- EPS
- FRPH 0.28
- SIGA 1.14
- Revenue
- FRPH $32,293,999.00
- SIGA $179,639,422.00
- Revenue This Year
- FRPH N/A
- SIGA N/A
- Revenue Next Year
- FRPH N/A
- SIGA $115.06
- P/E Ratio
- FRPH $90.97
- SIGA $7.39
- Revenue Growth
- FRPH 3.18
- SIGA 3.86
- 52 Week Low
- FRPH $24.72
- SIGA $4.95
- 52 Week High
- FRPH $33.00
- SIGA $9.62
- Technical
- Relative Strength Index (RSI)
- FRPH 44.53
- SIGA 57.13
- Support Level
- FRPH $25.12
- SIGA $8.31
- Resistance Level
- FRPH $25.77
- SIGA $8.82
- Average True Range (ATR)
- FRPH 0.56
- SIGA 0.32
- MACD
- FRPH 0.00
- SIGA -0.08
- Stochastic Oscillator
- FRPH 27.61
- SIGA 43.47
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.